Christopher S. Downs's most recent trade in Cns Pharmaceuticals Inc was a trade of 4,881 Option to purchase common stock done . Disclosure was reported to the exchange on Nov. 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cns Pharma Inc | Christopher S. Downs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2025 | 4,881 | 4,881 | - | - | Option to purchase common stock |